ReviewSleep and biological rhythms2025
Meta-analysis of the prevalence of obstructive sleep apnea and associated risk factors among Parkinson's disease.
Review in Sleep and biological rhythms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sleep disorders are the most distressing non-motor problems among Parkinson's disease (PD), whereas obstructive sleep apnea (OSA) is a type of sleep disorder that commonly occurs in Parkinson's disease. Therefore, we conducted this meta-analysis to estimate the prevalence of OSA in Parkinson's disease. A comprehensive search in CINAHL, Embase, Ovid MEDLINE, PubMed, Scopus, and Web of Science, following the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines, was conducted from inception to September 2023 to identify studies on the prevalence of PD patients with OSA. A Comprehensive Meta-Analysis software version 3.0 and R software with random-effects models were used for pooled prevalence and prediction interval analysis. We assessed heterogeneity using Supplementary Information: The online version contains supplementary material available at 10.1007/s41105-024-00561-w.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.